Bengaluru, India

Sathyabalan M


 

Average Co-Inventor Count = 24.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Sathyabalan M in Biotechnology

Introduction

Sathyabalan M is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the development of methods utilizing CRISPR technology. With a total of 3 patents to his name, Sathyabalan is recognized for his innovative approaches to protein production and modification.

Latest Patents

Sathyabalan's latest patents include groundbreaking work on the DNA-binding domain of the CRISPR system and the production of non-fucosylated and partially fucosylated proteins. His research focuses on a method of obtaining cells where fucosylation pathways are modified. This leads to the production of partially fucosylated and non-fucosylated protein products, specifically antibodies. The method employs CRISPR technology to target the Fut8 gene and GMD gene in cells. Such advancements are crucial for developing therapeutics and biomarkers, as well as for the diagnosis and prognosis of diseases.

Career Highlights

Sathyabalan is currently associated with Zumutor Biologics Inc., where he continues to push the boundaries of biotechnological research. His work is instrumental in advancing the understanding and application of CRISPR technology in the field of protein engineering.

Collaborations

Sathyabalan collaborates with talented individuals such as Bhargav Prasad and Divya Unnikrishnan, who contribute to the innovative environment at Zumutor Biologics Inc. Their combined expertise fosters a culture of creativity and scientific advancement.

Conclusion

Sathyabalan M's contributions to biotechnology through his patents and research are paving the way for future innovations in therapeutics and diagnostics. His work exemplifies the impact of inventive thinking in addressing complex biological challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…